ストックスクリーナーアプリを入手
6.9486
1.00%
-0.0714
前日終値:
$7.02
開ける：
$6.82
24時間の取引高:
2.51M
Relative Volume:
1.03
時価総額：
$788.38M
収益：
-
当期純損益:
$-144.32M
株価収益率:
-3.1874
EPS:
-2.18
ネットキャッシュフロー:
$-105.21M
1週間 パフォーマンス:
-13.02%
1か月 パフォーマンス:
+5.46%
6か月 パフォーマンス:
+47.56%
1年 パフォーマンス:
+89.37%
1日の値動き範囲:
$6.5736
$7.025
1週間の範囲:
$6.5736
$8.095
52週間の値動き範囲:
$2.25
$8.90
Compass Pathways Plc Adr Stock (CMPS) Company Profile
名前
Compass Pathways Plc Adr
セクター
電話
1-716-676-6461
住所
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS vs HCA, THC, FMS, UHS, ENSG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
6.945 | 796.89M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
541.06 | 119.17B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
241.39 | 20.45B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.40 | 13.11B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
204.85 | 12.61B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
213.79 | 12.54B | 4.11B | 239.98M | 193.10M | 4.12 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-10 | アップグレード | Oppenheimer | Perform → Outperform |
| 2025-06-23 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2025-02-27 | 開始されました | Stifel | Buy |
| 2024-07-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-04-01 | 開始されました | Morgan Stanley | Overweight |
| 2023-12-12 | 開始されました | Deutsche Bank | Buy |
| 2022-11-21 | 再開されました | Berenberg | Buy |
| 2022-11-01 | 開始されました | Loop Capital | Buy |
| 2021-10-29 | 開始されました | Oppenheimer | Outperform |
| 2021-07-13 | 開始されました | Citigroup | Buy |
| 2021-06-28 | 開始されました | Maxim Group | Buy |
| 2021-05-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-01 | 開始されました | ROTH Capital | Buy |
| 2020-10-14 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-13 | 開始されました | Berenberg | Buy |
| 2020-10-13 | 開始されました | Canaccord Genuity | Buy |
| 2020-10-13 | 開始されました | Cowen | Outperform |
| 2020-10-13 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Compass Pathways Plc Adr (CMPS) 最新ニュース
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Benzinga
Compass Pathways raises $200M from warrant exercises - Investing.com
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders - Sahm
Compass Pathways (NASDAQ:CMPS) Stock Price Down 6.9%Here's Why - MarketBeat
Sonoco Products posts upbeat Q4 earnings, joins Compass Pathways, Masimo, Itron and other big stocks moving higher on Tuesday - MSN
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - Bitget
Magic Mushrooms, Hard Cash: Compass Pathways’ Trial Win, Fast Raise - MarketBeat
Cathie Wood’s ARK sells DraftKings stock, buys Figma and Compass Pathways - Investing.com South Africa
Analysts Bullish on COMPASS Pathways plc (CMPS) Following Psychedelics Symposium and Model Updates - Finviz
Compass Pathways prices $150 million public offering of ADSs By Investing.com - Investing.com South Africa
Compass Pathways prices $150 million public offering of ADSs - Investing.com
Compass Pathways announces $150 million ADS offering - Investing.com India
Compass Pathways (NASDAQ:CMPS) Shares Gap UpShould You Buy? - MarketBeat
Rezolve AI PLC (NASDAQ:RZLV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Mister Car Wash, Inc. (NYSE:MCW) Given Consensus Rating of “Hold” by Analysts - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Compass Pathways announces $150 million ADS offering By Investing.com - Investing.com UK
COMPASS Pathways touts Phase III psilocybin wins in TRD, eyes FDA NDA and expedited review - Yahoo Finance
Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday - Benzinga
Compass Pathways stock soars after positive Phase 3 trial results By Investing.com - Investing.com India
Compass Pathways stock soars after positive Phase 3 trial results - Investing.com
Compass Pathways reports positive phase 3 results for depression drug - Investing.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Short Interest Update - Defense World
Compass Pathways to release new clinical data on psilocybin trials - Investing.com India
Compass Pathways to release new clinical data on psilocybin trials By Investing.com - Investing.com South Africa
What is Lifesci Capital’s Estimate for CMPS FY2025 Earnings? - Defense World
COMPASS Pathways Plc ADR (CMPS) Price Forecast: Bullish Reversal Gains Structure - FXEmpire
COMPASS Pathways plc's (NASDAQ:CMPS) institutional investors lost 16% over the past week but have profited from longer-term gains - Sahm
COMPASS Pathways (NASDAQ:CMPS) Stock Price Down 7.6%Should You Sell? - MarketBeat
Green Plains, Inc. (NASDAQ:GPRE) Given Average Rating of “Hold” by Analysts - Defense World
Nuclear Stocks To Watch Today – January 22nd - Defense World
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Expand Energy Corporation (NASDAQ:EXE) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Investors Buy Large Volume of COMPASS Pathways Call Options (NASDAQ:CMPS) - Defense World
COMPASS Pathways Target of Unusually High Options Trading (NASDAQ:CMPS) - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading Down 5.5%What's Next? - MarketBeat
Commonwealth Equity Services LLC Boosts Position in Fidelity Enhanced Emerging Markets ETF $FEMR - Defense World
CMPS: COMP360 is poised to transform TRD and PTSD care with rapid, durable efficacy and broad support - TradingView — Track All Markets
CMPS: COMP360 is set to transform psychiatric care for PTSD and TRD with rapid, durable outcomes - TradingView — Track All Markets
COMPASS Pathways (NASDAQ:CMPS) Sets New 1-Year HighShould You Buy? - MarketBeat
CMPS: COMP360 demonstrates rapid, durable efficacy in TRD and PTSD, supporting near-term commercialization - TradingView — Track All Markets
Compass Pathways stock rises after FDA accepts IND for PTSD treatment By Investing.com - Investing.com South Africa
Compass Pathways stock rises after FDA accepts IND for PTSD treatment - Investing.com
Compass Pathways (Nasdaq:CMPS) Enters Strategic Collaboration with Radial Health - Kalkine Media
Compass Pathways forms seventh strategic collaboration with Radial Health By Investing.com - Investing.com India
Compass Pathways forms seventh strategic collaboration with Radial Health - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Simplify Asset Management Inc. Purchases Shares of 290,000 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Why COMPASS Pathways plc (CMPS) Draws Both Optimism and Caution - Finviz
Compass Pathways Plc Adr (CMPS) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.22%
大文字化:
|
ボリューム (24 時間):